Caladrius Biosciences/ US1280582032 /
2022-09-14 10:00:00 PM | Chg. - | Volume | Bid1:59:04 AM | Ask1:59:04 AM | High | Low |
---|---|---|---|---|---|---|
0.4264USD | - | 26.95 mill. Turnover: 9.49 mill. |
0.4202Bid Size: 21,000 | 0.4210Ask Size: 5,900 | 0.6500 | 0.3820 |
GlobeNewswire
2022-03-22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busin...
GlobeNewswire
2022-03-15
Caladrius Biosciences to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on...
GlobeNewswire
2022-03-11
Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress
GlobeNewswire
2022-02-17
Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors
GlobeNewswire
2022-01-04
Caladrius Biosciences Announces Participation in Upcoming Conferences in January 2022
GlobeNewswire
2021-11-04
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
GlobeNewswire
2021-10-28
Caladrius Biosciences to Host Third Quarter 2021 Financial Results Conference Call on Thursday, Nove...
GlobeNewswire
2021-10-04
Caladrius Biosciences Announces Participation in Upcoming Conferences in October 2021
GlobeNewswire
2021-09-08
Caladrius Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
2021-09-01
Caladrius Biosciences Announces Appointment of Kristen K. Buck, M.D., as Chief Medical Officer
GlobeNewswire
2021-08-05
Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-07-29
Caladrius Biosciences to Host Second Quarter 2021 Financial Results Conference Call on Thursday, Aug...
GlobeNewswire
2021-06-22
Caladrius Biosciences to Assess its CLBS201 CD34+ Cell Therapy in Diabetic Kidney Disease
GlobeNewswire
2021-06-17
Caladrius Biosciences to Present at Noble Capital Markets Virtual Investor Forum during the 16th Ann...
GlobeNewswire
2021-06-01
Caladrius Biosciences Announces Participation in Upcoming Conferences in June 2021
GlobeNewswire
2021-05-12
Caladrius Biosciences Receives $1.4 Million of Non-Dilutive Capital Through New Jersey Technology Bu...
GlobeNewswire
2021-05-06
Caladrius Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-05-04
Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in May 2021